Combining machine learning with flow cytometry immunophenotyping of myeloid and lymphoid cell populations to distinguish subjects with prostate cancer (PCa) from benign prostatic hyperplasia (BPH)

View Poster

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

Read More...

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology

Read More...

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.